TIGERMED: POLL VOTING RESULTS OF THE 2024 ANNUAL GENERAL MEETING, THE 2025 FIRST A SHARE CLASS MEETING AND THE 2025 FIRST H SHARE CLASS MEETING HELD ON MAY 30, 2025

TIGERMED held its Shareholders' Annual General Meeting and Class Shareholders' Meeting on May 30, 2025, where all resolutions were formally approved. The meeting was chaired by Dr. Ye Xiaoping, with shareholders holding a total of 400,475,846 shares present, accounting for approximately 46.83% of the total shares with voting rights.The meeting approved the profit distribution plan for the 2024 fiscal year, which will distribute a final dividend of RMB 3.00 (tax included) for every 10 shares to shareholders, while H share shareholders will receive HKD 3.2450 (tax included) for every 10 shares. The record date for H share shareholders is June 16, 2025, and the company will temporarily suspend the handling of H share transfer registrations from June 16 to June 19, 2025.The meeting also approved multiple important proposals, including the 2024 annual report...Show More

TIGERMED held its Shareholders' Annual General Meeting and Class Shareholders' Meeting on May 30, 2025, where all resolutions were formally approved. The meeting was chaired by Dr. Ye Xiaoping, with shareholders holding a total of 400,475,846 shares present, accounting for approximately 46.83% of the total shares with voting rights.The meeting approved the profit distribution plan for the 2024 fiscal year, which will distribute a final dividend of RMB 3.00 (tax included) for every 10 shares to shareholders, while H share shareholders will receive HKD 3.2450 (tax included) for every 10 shares. The record date for H share shareholders is June 16, 2025, and the company will temporarily suspend the handling of H share transfer registrations from June 16 to June 19, 2025.The meeting also approved multiple important proposals, including the 2024 annual report, the work report of the Board of Directors and Supervisory Board, the financial statement report, the appointment of the auditing institution for the 2025 fiscal year, proposed amendments to the company's articles of association, and granting the Board of Directors a general authorization to issue and repurchase H shares. All ordinary resolutions were approved by more than half of the votes, while special resolutions were approved by more than two-thirds of the votes.